Tokyo, Dec. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059776) titled 'Utilization and cost estimation in patients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) in Japan - A Study Using MDV Database' on Dec. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Nippon Boehringer Ingelheim Co., Ltd
Condition:
Condition - IPF, PPF, and non-progressive ILD
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To describe the treatment patterns of antifibrotic drugs in patients with IPF and PPF in Japan
Basic objectives2 - Others
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applic...